Contact UsBiological Products
> Biopharmaceutical Industry Insight & News > Biological Products
| Product | Botulax? 50U, Botulax? 100U, Botulax? 200U | Company | Hugel, Inc. |
|---|---|---|---|
| Classification | Toxin | Active Ingredient | Clostridium Botulinum Toxin Type A Strain: Clostridium Botulinum CBFC26 |
| Reference Product | Approval Date | 2011 | |
| Indication | 1. Benign essential blepharospasm in adult patients, 18 years age or above 2. Temporary improvement of serious glabellar wrinkles ranging from moderate to severe associated with corrugators muscle and/or procerus muscle activities in adults aged between |
||
| Description |
Since 2009, “Botulax” has been marketed in 22 countries, including Korea, Japan, Thailand, Vietnam, Philippines, Chile, Peru, Uruguay, Panama, Kuwait, etc.
|
||
Korea Biomedicine Industry Association(KoBIA)
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
COPYRIGHT BY KoBIA. ALL RIGHTS RESERVED.